Does increased adherence to antihypertensive agents reduce vascular events, hospitalization, and healthcare costs?
Increased adherence to antihypertensive agents is associated with better health outcomes and economic gains.
Low adherence to AH agents is correlated with a higher risk of vascular events, hospitalization, and greater healthcare costs. An increased level of adherence to AH agents should provide a better health status for individuals and a net economic gain.
Dragomir et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: